MedTrace Logo

Assessment of PPG & PAT to Detect Upper Airway Obstruction in Patients With Obstructive Sleep Apnea

NCT01831583 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-04-15

No results posted yet for this study

Summary

The goal of this study is to collect raw waveform data for two separate noninvasive methods, both of which may be useful for the assessment of upper airway obstruction.

Conditions

  • Sleep Apnea, Obstructive

Interventions

DEVICE

Measurement of PPG waveforms

The ViSi Vital Signs Monitor will measure PPG waveforms for 4 hours.

DEVICE

Measurement of Pulse Arrival Time (PAT)

The ViSi Vital Signs Monitor will measure PAT waveforms for 4 hours.

Sponsors & Collaborators

  • Sotera Wireless, Inc.

    lead INDUSTRY

Principal Investigators

  • James Welch, MS · Sotera Wireless

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-08-31
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01831583 on ClinicalTrials.gov